Results

Total Results: 583 records

Showing results for "adverse drug events".
Users also searched for: pressure injury

21. PII: S0749-3797(01)00255-0 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - PII: S0749-3797(01)00255-0 Screening and Treating Adults for Lipid Disorders Michael P. Pignone, MD, MPH, Christopher J. Phillips, MD, MPH, David Atkins, MD, MPH, Steven M. Teutsch, MD, MPH, Cynthia D. Mulrow, MD, MSc, Kathleen N. Lohr, PhD Context: Screening and treatment of lipid disorders in people at high risk f…

22. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 April 09, 2001 Recommendations made by the USPSTF are independent of the U.…

23. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
    December 01, 2003 - Obesity is an increasingly significant U.S. health problem. Over 4 decades, the prevalence of obesity (body mass index [BMI], kilograms of weight divided by height in meters squared [kg/m2], ≥ 30) has increased from 13% to 31% in adults and the prevalence of overweight (BMI 25–29.9 kg/m2) has increased from 31% to 34%.…

24. Final Research Plan: Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/bacterial-vaginosis-in-pregnancy-to-prevent-preterm-delivery-screening
    May 17, 2018 - What are the adverse drug events related to metronidazole or clindamycin when used to treat bacterial

25. Archived: Evidence Summary: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
    December 15, 2003 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Obesity in Adults: Screening and Counseling, 2003 December 15, 2003 Recommendations made by the USPSTF are independent of the U.S. government. They s…

26. Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
    March 02, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Hepatitis C Virus Infection in Adolescents and Adults: Screening March 02, 2020 Recommendations made by the USPSTF are independent of the U…

27. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screeni
    July 05, 2005 - therapy at CD4+ T lymphocyte counts of >350 cells/mm 3 : disease progression, treatment durability, and drug … toxicity. … risk for cardiovascular complications and intolerable (causing discontinuation of therapy with the drug … ) side effects from HAART.

28. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
    July 05, 2005 - therapy at CD4+ T lymphocyte counts of >350 cells/mm 3 : disease progression, treatment durability, and drug … toxicity. … risk for cardiovascular complications and intolerable (causing discontinuation of therapy with the drug … ) side effects from HAART.

29. Draft Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/osteoporosis-screening-prevent-fractures
    August 12, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Osteoporosis to Prevent Fractures: Screening August 12, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They …

30. Archived: Final Evidence Summary: Depression in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
    December 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Depression in Adults: Screening December 15, 2009 Recommendations made by the USPSTF are independent of the U.S. government. They should not be…

31. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
    June 20, 2019 - therapy at CD4� T lymphocyte counts of �350 cells/mm3: disease progression, treatment durability, and drug … toxicity. … risk for cardiovascular complications and intolerable (causing discontinuation of therapy with the drug … ) side effects from HAART.

32. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
    July 15, 2007 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Lipid Disorders in Children: Screening July 15, 2007 Recommendations made by the USPSTF are independent of the U.S. government. They should…

33. Final Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening-prevent-fractures
    November 18, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Osteoporosis to Prevent Fractures: Screening November 18, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They …

34. Final Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening
    November 18, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Osteoporosis to Prevent Fractures: Screening November 18, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be …

35. Final Research Plan: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-b-virus-infection-screening
    March 14, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Hepatitis B Virus Infection in Adolescents and Adults: Screening March 14, 2019 Recommendations made by the USPSTF are independent of the U.S. government.…

36. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis June 11, 2019 Recommendations made by the U…

37. Archived: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2013
    April 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Human Immunodeficiency Virus (HIV) Infection: Screening April 15, 2013 Recommendations made by the USPSTF are independent of the…

38. Screening for Depression in Adult Patients in Primary Care Settings: An Update (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-wqedxmwdpdE5BmzcBeTmn
    December 01, 2009 - Screening for Depression in Adult Patients in Primary Care Settings: An Update Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review Elizabeth A. O’Connor, PhD; Evelyn P. Whitlock, MD, MPH; Tracy L. Beil, MS; and Bradley N. Gaynes, MD, MPH Background: In primary care setti…

39. Recommendation: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
    June 11, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Human Immunodeficiency Virus (HIV) Infection: Screening June 11, 2019 Recommendations made by the USPSTF are independent of the U.S. gover…

40. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-may-2014
    May 27, 2014 - archived Evidence Summary Hepatitis B Virus Infection: Screening, 2014 May 27, 2014 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and H…